- Home
- CBZ vs BLCO Comparison
CBZ vs BLCO Comparison
Compare CBZ & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBZ
- BLCO
- Stock Information
- Founded
- CBZ 1987
- BLCO 1853
- Country
- CBZ United States
- BLCO Canada
- Employees
- CBZ N/A
- BLCO N/A
- Industry
- CBZ Business Services
- BLCO Ophthalmic Goods
- Sector
- CBZ Consumer Discretionary
- BLCO Health Care
- Exchange
- CBZ Nasdaq
- BLCO Nasdaq
- Market Cap
- CBZ 3.9B
- BLCO 4.0B
- IPO Year
- CBZ N/A
- BLCO 2022
- Fundamental
- Price
- CBZ $72.42
- BLCO $11.28
- Analyst Decision
- CBZ Strong Buy
- BLCO Hold
- Analyst Count
- CBZ 1
- BLCO 12
- Target Price
- CBZ $86.00
- BLCO $15.59
- AVG Volume (30 Days)
- CBZ 491.1K
- BLCO 1.0M
- Earning Date
- CBZ 04-24-2025
- BLCO 04-30-2025
- Dividend Yield
- CBZ N/A
- BLCO N/A
- EPS Growth
- CBZ N/A
- BLCO N/A
- EPS
- CBZ 1.55
- BLCO N/A
- Revenue
- CBZ $2,157,189,000.00
- BLCO $4,829,000,000.00
- Revenue This Year
- CBZ $62.67
- BLCO $6.30
- Revenue Next Year
- CBZ $4.85
- BLCO $5.56
- P/E Ratio
- CBZ $46.94
- BLCO N/A
- Revenue Growth
- CBZ 32.27
- BLCO 11.94
- 52 Week Low
- CBZ $62.66
- BLCO $10.45
- 52 Week High
- CBZ $90.13
- BLCO $21.69
- Technical
- Relative Strength Index (RSI)
- CBZ 49.75
- BLCO 38.54
- Support Level
- CBZ $70.66
- BLCO $10.83
- Resistance Level
- CBZ $73.43
- BLCO $11.78
- Average True Range (ATR)
- CBZ 2.75
- BLCO 0.59
- MACD
- CBZ 0.29
- BLCO -0.03
- Stochastic Oscillator
- CBZ 56.62
- BLCO 23.58
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.